U.S. Markets open in 5 hrs 15 mins

Nymox Pharmaceutical Corporation (NYMX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.52-0.08 (-2.22%)
At close: 4:00PM EDT
People also watch
SPHSEBIOPBMDNVGNCYCC
  • G
    Gary
    Gary
    Fenix seems to think the pathway to approval for cancer will be easier than BPH, but I am greedy and want them both
  • s
    stockinvestor56
    stockinvestor56
    Anyone fed up and selling on the next rip? ...not me
  • L
    Longtermgonedaily
    Longtermgonedaily
    Institution ownership has gone up. Blackrock has over a million shares now.
  • L
    Longtermgonedaily
    Longtermgonedaily
    Why no movement? They're getting more info out, releasing ERs on time and attending conferences?
  • s
    stockinvestor56
    stockinvestor56
    "Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce recent completion of private placements with proceeds totaling US $3.0 million. There were no warrants or fees associated with the transactions. The placements were with long-term shareholders of the Company, and will be used for general corporate purposes."

    Is there anyway of knowing how many shares were sold for the $3 million. Curious to know at what share price. An SEC filing doesn't need to occur here??
  • s
    stockinvestor56
    stockinvestor56
    Wow less than 5K volume 2 hours into trading!
  • G
    Gary
    Gary
    Yippee, that are presenting in September. That's a start
  • B
    Boomer
    Boomer
    Question??? The AUA Presentation is being given on Saturday morning 7:00am-8:00am. Why so early? Who's going to be up????
  • G
    Gary
    Gary
    Aqua will be happy. They filed their Q2 report
  • a
    ali
    ali
    this stock is #$%$ up
  • a
    a Yahoo! Local User
    a Yahoo! Local User

    This article talks about EU average approval timelines. We could be looking at almost 400 days from submission.

    http://www.latimes.com/science/sciencenow/la-sci-sn-fda-european-medicine-20170405-story.html

    Speed up drug approvals at FDA? It's already faster than Europe's drug agency
    Amidst Trump's calls for faster drug approvals, new research finds that FDA's process is more efficient than Europe's
    www.latimes.com
  • W
    Wolf
    Wolf
    Markets were expecting more than just a "Symposium"
  • s
    stockinvestor56
    stockinvestor56
    Robinson buys 15,000 more shares between 7/28-8/1. Wonder if this has any impact on the timing of news release?
  • s
    stockinvestor56
    stockinvestor56
    Aqua, why so quiet?
  • R
    Rick
    Rick
    So what is the deal on the private placement of $3 million? Is that good?
  • l
    lisa
    lisa
    Wow That was fast!
  • D
    DJ
    DJ
    Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Director James George Robinson purchased 11,500 shares of the business’s stock in a transaction that occurred on Friday, July 7th. The stock was bought at an average cost of $4.00 per share, with a total value of $46,000.00. Following the acquisition, the director now owns 3,046,550 shares of the company’s stock, valued at approximately $12,186,200. The purchase was disclosed in a document filed with the Securities & Exchange Commission,
  • d
    davidnadon
    davidnadon
    New Insider Filing on Director JAMES GEORGE ROBINSON: #insideri.com/1651844_000165…
    Imagejustalittletumblweed
  • d
    davidnadon
    davidnadon
    New Insider Filing
  • l
    lisa
    lisa

    Saw this on ARRY board- probabilities of FDA approval %- study is 2 years old could not find updated info
    https://www.bio.org/sites/default/files/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf